Abstract
Background
Little is known about the etiology of childhood diarrhea in the United Arab Emirates (UAE) especially after the introduction of rotavirus vaccines. This study aimed to identify gastrointestinal pathogens in children with diarrhea (cases) and the carriage rate of these pathogens in asymptomatic children (controls).
Methods
Stool samples were collected from 203 cases and 73 controls who presented to two major hospitals in Al Ain city, UAE. Samples were analyzed with Allplex™ Gastrointestinal Full Panel Assay for common entero-pathogens. The association between diarrhea and the isolated pathogens was calculated in a multivariate logistic regression model. The adjusted attributable fractions (aAFs) were calculated for all pathogens significantly associated with cases.
Results
At least one pathogen was identified in 87 samples (42.8%) from cases and 17 (23.3%) from controls (P < 0.001). Rotavirus, norovirus GII and adenovirus were significantly more prevalent in cases. Their aAFs with 95% ci are 0.95 (0.64, 1.00) for rotavirus, 0.86 (0.38, 0.97) for norovirus GII and 0.84 (0.29, 0.96) for adenovirus. None of the 13 bacteria tested for were more commonly found in the cases than in controls. Cryptosporidium spp. were more significantly detected in cases than in controls. Co-infections occurred in 27.9% of the children. Viruses and parasites were significantly more likely to occur together only in the cases.
Conclusions
Multiplex PCR revealed high positivity rates in both cases and controls which demand a cautious interpretation. Rotavirus remains the main childhood diarrhea pathogen in UAE. Effective strategies are needed to better control rotavirus and other causative pathogens.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12879-020-05693-1.
Keywords: Rotavirus, Multiplex PCR, Attributable fractions, Cryptosporidium, Diarrhea
Introduction
Infectious diarrhea is a main reason for children’s visits to clinics and emergency rooms. Globally, it is the fifth leading cause of death among children younger than 5 years particularly in lower-income countries [1]. While the responsible microorganisms include a variety of viruses, bacteria and parasites, the majority of diarrhea episodes do not necessitate antibacterial or antiparasitic treatment. The risk of transmission within a household, at school or throughout the community varies according to the causative microorganism. Thus, identifying the organism responsible for the diarrhea is important; particularly for microorganisms associated with diarrhea outbreaks such as various strains of diarrheagenic Escherichia coli, Salmonella spp., Vibrio cholerae, Clostridium difficile, noroviruses and adenoviruses [2].
Although it has been shown that, in the United Arab Emirates (UAE), 87% of parents seek medical care for their children when they develop gastroenteritis with 10% of these cases requiring hospitalization with an average length of stay of 2.6 days, little is known of the microbiology of gastroenteritis in this country [3]. A hospital-based surveillance study conducted prior to rotavirus vaccine introduction showed that rotavirus gastroenteritis accounted for 50.3% of all gastroenteritis hospitalizations and predominantly affected children younger than 2 years [4]. Although rotavirus vaccine became part of the national immunization program in 2013, there is a lack of information on the distribution of other microorganisms involved in childhood diarrhea in the country.
Usual laboratory investigations for gastroenteritis focus on salmonella, shigella and viruses such as rotavirus. Other possible microorganisms go therefore undetected. Traditional diagnostic tests such as culture, immunoassay and microscopic examination are time-consuming, require special laboratory setup and often lack sensitivity. Culturing most viruses that cause diarrhea is difficult. Other techniques for virus identification such as electron microscopy and immunoassay demand special expertise which is often lacking in many clinical diagnostic laboratories [5, 6].
Multiplex polymerase chain reaction (PCR) based testing has been recently added to the list of microbiological diagnostic tools for several infectious diseases. It allows rapid and simultaneous amplification of several targets with good sensitivity and specificity [5, 7]. Although used in some tertiary hospitals in the UAE, this method, has not yet been evaluated at a population level, where co-infections, as well as asymptomatic carriage of pathogens may exist. If the use of multiplex PCR extends throughout the UAE health care system, it might lead to an overestimation of positive results for diarrhea pathogens in children who might just be asymptomatic carriers, potentially resulting in unnecessary or inappropriate therapy [8]. The aim of this study is to understand the etiology of acute childhood gastroenteritis following rotavirus vaccine introduction in the UAE using a multiplex PCR. We therefore commenced a case-control study to examine the prevalence of different enteric pathogens among children younger than 5 years of age with diarrhea and compare the findings of those with diarrhea-free children.
Methods
Study setting, design and enrollment
The study was conducted at two major government-run referral hospitals (Al Ain and Tawam hospitals) in Al Ain, a large inland city in the Eastern Region of the Emirate of Abu Dhabi, UAE with a population estimates of 766,936 people [9]. The UAE is a federal union of seven distinct States-Emirates with the Emirate of Abu Dhabi being the largest and the political capital of the country. Health care is provided for all nationals as mandated by the constitution. National healthcare indicators are equivalent to those in high-income countries with a total expenditure on health as a percentage of gross domestic product being 4.0 in 2010 [10].
Between December 2017 and April 2019, after obtaining parental informed consent, stool specimens were collected from children less than 5 years of age who presented to the two hospitals with diarrhea, defined as at least three loose stools within the previous 24 h, defined as “cases”. During the same period, stool specimens were collected from children attending the same two hospitals without diarrheal disease in the last 30 days, defined as “controls”. Only one stool sample was collected from each participating child. The exclusion criteria for cases included current antibiotic treatment, chronic conditions (e.g., immune deficiency or cystic fibrosis), long-term immunosuppressive therapy and severe or life- threatening co-morbidity. The exclusion criteria for controls included acute infection (e.g., respiratory infection) and having a sibling recruited as a case or control. We also obtained data on demographics, clinical characteristics and exposures (e.g., history of sick contact with diarrhea) through a brief survey of parents at time of enrollment.
Laboratory testing
Following collection, fecal specimens were transported on a daily basis to the principal investigator’s research laboratory at the UAE University and stored at − 80 °C until further analysis. An automated nucleic acid extraction instrument (Microlab Nimbus IVD system; Hamilton, Reno, Nevada, USA) was used for the extraction of both RNA and DNA from the stool samples. A weighed aliquot of stool sample was suspended in 1-ml of ASL buffer (Qiagen, Valencia, CA, USA) and incubated for 10 min at room temperature. After clarification by high-speed centrifugation, the sample was loaded into the Nimbus equipment for nucleic acid extraction. After nucleic acid extraction, PCR reactions were set up and run on the CFX96 Real Time Detection System (Bio-Rad, Hercules, CA, USA). For that purpose, we used a multiplex one-step real-time PCR platform, the Allplex™ Gastrointestinal Full Panel Assay (Seegene, Seoul, South Korea) as per manufactures’ instructions [11, 12]. This assay has four panels that test for six viruses, 13 bacteria and six parasites. The viral panel detects adenovirus, astrovirus, norovirus GI, norovirus GII, rotavirus and sapovirus. The first bacterial panel detects Enteroaggregative E. coli, EAEC (aggR), Enteropathogenic E. coli, EPEC (eaeA), Escherichia coli O157 (E. coli O157), Enterotoxigenic E. coli, ETEC (lt/st), hypervirulent Clostridium difficile and Enterohemorrhagic E. coli, Shiga toxin-producing E. coli, STEC (stx1/2). The second bacterial panel detects Aeromonas spp., Campylobacter spp., Clostridium difficile toxin B, Salmonella spp., Shigella spp./ Enteroinvasive E. coli (EIEC), Vibrio spp. and Yersinia enterocolitica. The parasitic panel detects Blastocystis hominis, Cryptosporidium spp., Cyclospora cayetanensis, Dientamoeba fragilis, Entamoeba histolytica and Giardia lamblia. The PCR reaction was performed under the following cycling conditions: 20 min at 50 °C for one cycle; 15 min at 95 °C for one cycle; 10 s at 95 °C, 1 min at 60 °C and 30 s at 72 °C for 45 cycles; 10 s at 95 °C, 44 times. Seegene Viewer Software (Seegene, Seoul, South Korea) was used for detection and data analysis. Samples were classified as pathogen positive at a cycle threshold value of < 40 as per manufacturer’s instructions [12].
Data analysis
The descriptive results were expressed as number of participants and percentages. Proportions were compared with the Chi squared or Fisher exact test for small values. As the continuous variables did not follow a normal distribution (as confirmed by the Shapiro-Wilk test), they were expressed as median values and interquartile range (IQR, i.e. 25th and 75th percentile) and were compared with the non-parametric Kruskal Wallis test.
The association between diarrhea and the isolated pathogens was calculated in a multivariate penalized maximum likelihood logistic regression model (Firth’s method) to take into account results with zero participants. The model was corrected for age as a confounder, and the results were expressed as adjusted odds ratios (aOR) with 95% confidence intervals (ci) and their respective P values. When there were zero participants in both cases and controls for an individual pathogen, the model could not be computed and thus no results could be reported.
As the number of controls was significantly less than the cases, although we used a penalized maximum likelihood logistic regression model to adjust for age and gender between cases and controls, we still decided to validate the obtained results by executing the same analyses in a post-hoc frequency age-matching case-control analysis. The cases and controls were age-matched within a range of 6 months and were analyzed in a conditional logistic regression model. The association between diarrhea and the isolated pathogens was calculated in an exact logistic regression model (Cox and Snell method) to take into account results with zero participants. The results were expressed as adjusted odds ratios (aOR) with 95% ci and their respective P value. The results of the unmatched and age-matched analyses were compared.
Adjusting for potential confounders in the above model, we also calculated, for each pathogen significantly associated with diarrhea in the logistic model, the adjusted attributable fraction (aAF), which is the proportional reduction in diarrhea that would occur if exposure to the respective pathogen was eliminated. aAF (with 95% ci) was calculated from the aOR, with the Woolf approximation for small samples, using the equation:
Co-infection amongst the three groups of pathogens was analysed in a logistic model. We calculated their respective odds ratio (OR), with 95% ci and also analyzed the existence of any interaction amongst them, i.e. if the presence of parasites, for example, increased the likelihood of infection with bacteria or viruses, and so on. For all calculations, the statistical software package STATA version 15 was used (StataCorp, Texas, USA) and a two-tailed P value < 0.05 defined statistical significance.
Results
Study population
A total of 276 stool samples were analyzed involving 203 samples from cases and 73 samples from controls (Fig. 1). Cases (median age of 17 months, IQR: 8–23) were significantly older than controls (P = 0.01) who had a median age of 11 months (IQR: 2–26). History of sick contact was provided in 30.6% of cases in comparison to approximately 5% in controls (Table 1).
Table 1.
Cases n = 203 |
Controls n = 73 |
P | |
---|---|---|---|
Males | 101 (49.8) | 33 (45.2) | 0.50* |
Age in months: median (IQR) | 17 (8, 23) | 11 (2, 26) | 0.01† |
Diarrhea | 203 (100) | 0 (0) | < 0.001* |
Type | |||
Bloody | 7 (3.6) | 0 (0) | NA |
Watery | 95 (48.5) | 0 (0) | NA |
Mucous | 54 (27.5) | 0 (0) | NA |
Duration (hour) | |||
1–96 | 153 (76.9) | 0 (0) | NA |
97–120 | 25 (12.6) | 0 (0) | NA |
≥ 121 | 21 (10.5) | 0 (0) | NA |
Frequency/24 h | |||
1–3 | 34 (17.1) | 0 (0) | NA |
4–5 | 54 (27.1) | 0 (0) | NA |
≥ 6 | 111 (55.8) | 0 (0) | NA |
Vomiting | 161 (80.9) | 2 (2.8) | < 0.001* |
Duration (hour) | |||
1–24 | 58 (34.5) | 0 (0) | NA |
25–48 | 71 (42.2) | 0 (0) | NA |
≥ 49 | 39 (23.2) | 0 (0) | NA |
Frequency/24 h | 0.2* | ||
1 | 19 (11.4) | 1 (33.3) | |
2–4 | 71 (42.8) | 0 (0) | |
≥ 5 | 76 (45.8) | 2 (66.7) | |
Fever | 120 (60.3) | 4 (5.5) | < 0.001* |
Duration (hour) | 0.008* | ||
1–24 | 38 (28.8) | 4 (80) | |
25–48 | 59 (44.7) | 0 (90) | |
≥ 49 | 35 (26.5) | 1 (20) | |
Max recorded fever (°C) | 0.7* | ||
37.1–38.4 | 71 (55.9) | 2 (50) | |
38.5–38.9 | 42 (33.1) | 2 (50) | |
≥ 39.0 | 14 (11.0) | 0 90) | |
Abdominal pain | 97 (49.5) | 2 (2.7) | < 0.001* |
Consumption of meal outside home | 19 (9.5) | 2 (3.3) | 0.11 |
History of contact | 61 (30.6) | 3 (4.9) | < 0.001* |
Travel abroad in previous 3 months | 13 (6.5) | 4 (6.5) | 0.99 |
* Chi squared or Fisher exact test; † Kruskal Wallis test; IQR interquartile range; NA not applicable
Pathogen prevalence
A positive PCR result for at least one pathogen was identified more often in 87 samples (42.8%) from cases than in 17 (23.3%) from controls (P < 0.001) (Table S1). Overall, the OR of isolating a pathogen, especially a virus (OR = 15.8), were always significantly higher in cases than in controls, in both the unmatched and age-matched multivariate analysis (Table 2). From all the six viruses tested for, only rotavirus, norovirus GII and adenovirus were found significantly more often in the cases than in controls, in both the unmatched and age-matched multivariate analysis (Table 3). However, none of the 13 bacteria tested for were more commonly found in the cases than in controls, in both the unmatched and age-matched multivariate analysis (Table 3). From all the six parasites tested for, only Cryptosporidium was found significantly more often in cases than in controls in the unmatched analysis, but that significance disappeared in the age-matched multivariate analysis (Table 3). Overall, the top three pathogens that were significantly more prevalent in a multivariable logistic regression model include rotavirus, norovirus GII and adenovirus (in a descending order). Their adjusted attributable fractions (aAFs) with 95% ci were 0.95 (0.64, 1.0) for rotavirus, 0.86 (0.38, 0.97) for norovirus GII and 0.84 (0.29, 0.96) for adenovirus (Table S2). Of note, these prevalent pathogens were detected throughout the year (Figure S1). Further, rotavirus and norovirus GII were detected across all studied age groups. However, adenovirus was more prevalent among children younger than 24 months when compared with older children (Table S3).
Table 2.
Univariate Analysis | Multivariate Analysis | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Unmatched analysisa | Age-matched analysisb | Unmatched analysisa | Age-matched analysisb | |||||||
Cases n = 203 |
Controls n = 73 |
aOR (95 ci) |
P | aOR (95 ci) |
P | aOR (95% ci) |
P | aOR (95% ci) |
P | |
Viruses | 119 (58.6) | 6 (8.2) | 15.8 (6.5, 38.1) | < 0.001 | 14.3 (5.8, 35.4) | < 0.001 | 18.6 (7.6, 45.6) | < 0.001 | 16.7 (6.7, 43.0) | < 0.001 |
Bacteria | 84 (41.4) | 17 (23.3) | 2.3 (1.2, 4.2) | 0.009 | 1.8 (0.9, 3.5) | 0.05 | 2.1 (1.0, 4.2) | 0.03 | 1.8 (0.84, 3.9) | 0.1 |
Parasites | 32 (15.8) | 2 (2.8) | 5.9 (1.3, 25.8) | 0.02 | 10.1 (1.3, 77.7) | 0.03 | 12.15 (2.7, 54.0) | 0.01 | 20.34 (2.5, 166.9) | 0.005 |
a Penalized maximum likelihood logistic regression model, with correction for age; b Conditional age-matched (6-months blocks) exact logistic regression model; aOR adjusted odds ratio; ci confidence intervals
Table 3.
Unmatched analysisa | Age-matched analysisb | |||||||
---|---|---|---|---|---|---|---|---|
Cases | Controls | aOR | 95% ci | P | aOR | 95% ci | P | |
n = 203 | n = 73 | |||||||
Viruses | ||||||||
Rotavirus | 43 (21.2) | 1 (1.4) | 19 | 2.5, 140.0 | 0.004 | 21.4 | 2.8, 161.7 | 0.003 |
Norovirus GII | 39 (19.2) | 2 (2.7) | 8.4 | 1.98, 35.9 | 0.004 | 6.9 | 1.6, 30.1 | 0.01 |
Adenovirus | 35 (17.2) | 2 (2.7) | 7.7 | 1.8, 33.1 | 0.006 | 6.1 | 1.4, 26.9 | 0.016 |
Sapovirus | 13 (6.4) | 2 (2.7) | 2.4 | 0.52, 10.87 | 0.20 | 2.4 | 0.5, 11.9 | 0.20 |
Norovirus GI | 5 (2.4) | 0 (0) | 1.4 | 0.5, 4.3 | 0.35 | 1.1 | 0.2, 12.1 | 0.66 |
Astrovirus | 4 (1.9) | 0 (0) | 1.3 | 0.6, 4.2 | 0.38 | 1.1 | 0.1, 11.8 | 0.93 |
Bacteria | ||||||||
Aeromonas spp. | 11 (5.4) | 1 (1.4) | 4.33 | 0.54, 34.35 | 0.1 | 4.71 | 0.56, 39.7 | 0.1 |
EPEC (eaeA) | 36 (17.7) | 6 (8.2) | 2.32 | 0.93, 5.79 | 0.07 | 1.8 | 0.70, 4.64 | 0.2 |
ETEC (lt/st) | 7 (3.4) | 2 (2.7) | 1.2 | 0.24, 6.0 | 0.8 | 1.73 | 0.32, 9.29 | 0.5 |
EAEC (aggR) | 21 (10.3) | 7 (9.6) | 1.04 | 0.42, 2.57 | 0.9 | 0.94 | 0.37, 2.42 | 0.9 |
Clostridium difficile toxin B | 14 (6.9) | 6 (8.2) | 0.78 | 0.28, 2.12 | 0.6 | 0.6 | 0.21, 1.71 | 0.3 |
Clostridium difficile hypervirulent | 1 (0.5) | 1 (1.4) | 0.2 | 0.11, 3.6 | 0.2 | 0.65 | 0.04, 10.4 | 0.7 |
Campylobacter spp. | 4 (1.9) | 0 (0) | 1.2 | 0.6, 4.2 | 0.4 | 2.1. | 0.19, 14.2 | 0.5 |
Salmonella spp. | 11 (5.4) | 0 (0) | 2.1 | 0.6, 5.0 | 0.1 | 3.0 | 0.46, 15.2 | 0.2 |
Shigella spp./EIEC | 5 (2.4) | 0 (0) | 1.2 | 0.5, 4.1 | 0.8 | 1.2 | 0.09, 20.1 | 0.8 |
Yersinia enterocolitica | 1 (0.5) | 0 (0) | 0.2 | 0.1, 3.4 | 0.1 | 0.2 | 0.006, 19.4 | 1.0 |
E coli O157 | 3 (1.5) | 0 (0) | 1.0 | 0.1, 4.0 | 0.4 | 0.8 | 0.08, 11.3 | 1.0 |
STEC (stx1/2) | 2 (0.9) | 0 (0) | 0.2 | 0.2, 3.3 | 0.8 | 1.2 | 0.09, 14.7 | 0.8 |
Parasites | ||||||||
Cryptosporidium spp. | 22 (10.8) | 1 (1.4) | 7.8 | 1.02, 59.6 | 0.04 | 7.07 | 0.88, 56.43 | 0.06 |
Dientamoeba fragilis | 3 (1.5) | 1 (1.4) | 1.01 | 0.99, 1.04 | 0.09 | 1.15 | 0.10, 12.8 | 0.9 |
Giardia lamblia | 4 (1.9) | 0 (0) | 1.19 | 0.2, 4.1 | 0.8 | 1.26 | 0.15, 14.8 | 0.8 |
Blastocystis hominis | 6 (2.9) | 0 (0) | 1.30 | 0.2, 4.2 | 0.9 | 4.8 | 0.58, 18.5 | 0.1 |
a Penalized maximum likelihood logistic regression model, with correction for age; b Conditional age-matched (6-months blocks) exact logistic regression model; aOR adjusted odds ratio; ci confidence intervals
Co-infections
Co-infections occurred in 27.9% of the children, with parasites being present with either viruses or bacteria in 23 children (8.3%). Although amongst all participants, there were no interactions among the three groups of pathogens (all P values > 0.05) in the logistic regression analysis (Table 4), viruses and parasites were significantly more likely to occur together only in the cases (Table 4). Cases had a significant higher number of pathogens as compared to controls, with ≥3 pathogens detected in 7.5% of cases, compared with 2.7% of controls (Table S1). The heatmap (Figure S2) shows that EPEC and norovirus GII infection were the most frequent co-infections occurring in 14 children followed by co-infection with EPEC and EAEC in nine children. Of note, EPEC was identified in (17.7%) of cases and (8.2%) of controls (P = 0.07).
Table 4.
Cases (n = 203) | Controls (n = 73) | |||||
---|---|---|---|---|---|---|
aOR* | 95% ci | P | aOR* | 95% ci | P | |
Bacterial and parasitic infection | 0.96 | 0.44, 2.07 | 0.92 | 0.51 | 0.05, 5.0 | 0.56 |
Viral and parasitic infection | 0.21 | 0.09, 0.49 | < 0.001 | 13.2 | 0.71, 244.0 | 0.08 |
Bacterial and viral infection | 1.37 | 0.77, 2.43 | 0.27 | 0.63 | 0.07, 5.86 | 0.69 |
Discussion
By applying a molecular diagnostic test (i.e., multiplex PCR), this study reveals that in the UAE, rotavirus remains the main pathogen detected in children younger than 5 years of age who present with diarrhea despite the introduction of rotavirus vaccine into the country several years earlier. These results are in agreement with findings from the Global Rotavirus Surveillance Network that included 16 countries in the Americas and Africa regions [13]. In contrast, the introduction of rotavirus vaccines has contributed to ranking norovirus as the leading cause of acute gastroenteritis in U.S. children [14]. As of April 2020, 107 countries have introduced rotavirus vaccines with variable vaccine coverage between high- and low-income countries [15]. Although high-income countries, on average, have lower rotavirus vaccine coverage in comparison to low and lower-middle income countries, the UAE has rotavirus vaccine coverage estimates consistently above 90% for first and last vaccine doses over the past 5 years [16, 17]. Nevertheless, the department of health in Abu Dhabi, UAE was notified of 1144 cases of rotavirus infections in the year 2018 in comparison to only 844 cases in 2017 [18]. Although this increase could reflect improved reporting rather than actual increase in cases, prospective surveillance for rotavirus including evaluation of genotypes distribution remains essential. Moreover, real-world effectiveness of rotavirus vaccines varies according to the setting. Formal evaluation and assessment of the true rotavirus vaccines effectiveness in the UAE population is currently lacking and highly needed.
Norovirus GII was the second prevalent pathogen among the studied children with aAF of 0.86. While the role of norovirus in childhood gastroenteritis is well established in many parts of the world, limited data exist about the contribution of norovirus to the burden of diarrheal disease in the UAE and neighboring countries. A systematic review of studies from 15 out of the 24 countries of the Middle East and North Africa region revealed norovirus infection rates between 0.82 and 36.84% with GII.4 being the most predominant genotype detected [19]. Given recent advances of candidate norovirus vaccines, there is a need for a comprehensive evaluation of local and regional norovirus disease burden including seasonality and strains distribution across the different age groups [20].
Adenoviruses were the third leading cause of diarrhea in our cohort with aAF of 0.84. The clinical course of adenovirus gastroenteritis is often mild and indistinguishable from other viral gastroenteritis. Of note, the Allplex assay is only able to detect enteric adenoviruses belonging to species F (types 40 and 41). Other diarrhea-causing adenovirus species such as A, C and D will be missed when using the Allplex assay [21–24]. This is particularly relevant in the immunocompromised pediatric patients where monitoring adenovirus DNA levels in stools has been suggested to evaluate the benefit of anti-adenovirus pre-emptive therapy [25].
Although none of the 13 bacteria tested for using the Allplex assay were more significantly prevalent in the cases than in controls, diarrheagenic E. coli including EPEC, ETEC and EAEC were frequently detected in our studied children. EPEC and EAEC are of debatable diarrheal causation. EPEC is subdivided into typical EPEC (tEPEC) and atypical EPEC (aEPEC) strains based on the presence of EPEC adherence factor plasmid [26]. Recent cumulative data showed that aEPEC are more common than tEPEC. However, given the presence of several virulence factors and association with serious disease, tEPEC is still considered a true pathogen. Nevertheless, it remains unclear if certain aEPEC serotypes are linked with human disease [27]. Further, EAEC has been reported in patients with bloody diarrhea and are probably pathogens. However, it remains unclear if antibiotics are warranted [28]. The 2017 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea recommend stool testing for selected bacterial pathogens including Salmonella, Shigella, Campylobacter, Yersinia, C. difficile, and STEC in people with diarrhea accompanied by fever, bloody or mucoid stools, severe abdominal cramping or tenderness, or signs of sepsis. The IDSA guidelines emphasize that results obtained by culture-independent diagnostic testing, including molecular assays such as multiplex PCR tests, should be cautiously interpreted within the clinical context as these assays may not necessarily detect viable organisms [29].
Cryptosporidium spp. were found significantly more often in cases than in controls in the unmatched analysis, but not in the age-matched multivariate analysis. Cryptosporidium spp. are major cause of gastroenteritis with variable presentations ranging from asymptomatic shedding, self-limiting watery non-bloody diarrhea to a prolonged life-threatening disease in the immunocompromised individuals [30]. The unexpected high rate of Cryptosporidium detection in the studied children raises public health concerns related to potential contamination of drinking water or food. In a study conducted in Sharjah, UAE, 19.4% of stool samples collected from asymptomatic expatriates working in food industry and other domestic occupations during the years 2009 to 2011 were found positive for Cryptosporidium species [31]. In 2018, the department of health in Abu Dhabi, UAE, received nine notifications of Cryptosporidium, all involving children younger than 10 years of age and requiring hospitalization. There was no identifiable source of infection apart from few patients reporting travel history prior to developing symptoms. Of note, reporting Cryptosporidium is not mandatory in the UAE and cases are often notified to health authorities as part of foodborne illnesses investigations [18]. Taken together, we recommend making Cryptosporidium a mandatory reportable disease in the UAE. In addition, further studies are needed to better understand the true prevalence of Cryptosporidium and sources of infection in the country.
Co-infections were found in 27.9% of the studied children. In particular, viruses and parasites were significantly more likely to occur together, but only in the cases. This confirms a previously reported case-control study conducted in southwest China showing that co-infections with two enteric pathogens was higher in cases than in controls (20.1% vs. 5.3%, P < 0.05), with rotavirus and norovirus GII being the most common co-infection in symptomatic children and seemingly aggravating the severity of diarrhea [32]. One possible explanation for this aggravation includes the potential for synergistic interaction between the two pathogens resulting in enhanced pathogenicity [33].
This study demonstrates that using molecular multiplex assay is a highly sensitive method for detecting gastrointestinal pathogens. As many pathogens were found in both cases and controls, interpretation of the multiplex PCR results requires a cautious approach. One recommendation is to use a stepwise diagnostic algorithm where screening is initially performed for the pathogens with high aAF; namely rotavirus, norovirus GII and adenovirus. If the initial test is negative, testing for other pathogens is recommended [34]. Alternatively, combining PCR results with the traditional culture results might be useful to ascertain the true viability of the detected pathogen.
This study has few limitations. First, the study was performed only on children presenting exclusively to two local hospitals in Al Ain city who may have different sociodemographic and health characteristics when compared to other children in other parts of the country. Therefore, selection bias is possible, and the study implications cannot be generalized beyond the study settings. Second, although rotavirus was the most predominant pathogen, the lack of knowledge of the children’s rotavirus vaccination status makes it difficult to assess the impact of vaccination on them as well as to evaluate the possibility that positive rotavirus isolates in the studied children could be secondary to recent vaccination. Third, as we have not checked if the controls developed gastrointestinal symptoms days or weeks after the sample collection, introduction of bias cannot be ruled out. One solution would be to make a telephone call 1 month later to establish whether controls had developed acute gastroenteritis after stool sampling, and in the affirmative, exclude them from the analysis. Fourth, controls were younger than cases probably due to the ease of collecting stools from younger children wearing diapers. To overcome this potential bias, we used a logistic regression model to adjust for age and validated the obtained results by executing the same analyses in a post-hoc frequency age-matching case-control analysis. Finally, we had a low number of asymptomatic controls, but this was mitigated by the methods described earlier for the analysis.
Conclusion
The use of a multiplex PCR has resulted in detection of many pathogens in both cases and controls. Careful interpretation of the test result is therefore needed before making treatment decisions. As rotavirus remains the main pathogen detected among children with diarrhea in UAE, there is a need for better vaccine strategies in the country. Comprehensive evaluation of the true prevalence of Cryptosporidium and sources of infection in the country are warranted.
Supplementary Information
Acknowledgements
Not applicable
Abbreviations
- UAE
United Arab Emirates
- PCR
Polymerase chain reaction
- EAEC (aggR)
Enteroaggregative E. coli
- EPEC (eaeA)
Enteropathogenic E. coli
- E. coli O157
Escherichia coli O157
- ETEC (lt/st)
Enterotoxigenic E. coli
- EIEC
Enteroinvasive E. coli
- STEC (stx1/2)
Shiga toxin-producing E. coli
- IQR
Interquartile range
- OR
Odds ratio
- aOR
Adjusted odds ratios
- ci
Confidence intervals
- aAF
Adjusted attributable fraction
- aEPEC
Atypical Enteropathogenic E. coli
- tEPEC
Typical Enteropathogenic E. coli
- IDSA
Infectious Diseases Society of America
Authors’ contributions
ARA designed the study, coordinated data collection and analysis and drafted the manuscript. KAD, SA, JI, GG and MI recruited study participants and coordinated data collection. JG performed laboratory analysis. SAH participated in study design. HN participated in study design, data analysis and contributed to manuscript writing. All authors read and approved the final manuscript
Funding
The study was funded by a research grant from the United Arab Emirates University (No. 31 M319). The funding source did not participate in the study design, data collection, analysis and interpretation of the data, or the decision to submit the manuscript for publication.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
Ethics approval was granted by the Al Ain Medical District Human Research Ethics Committee (ERH-2016-5482-16-87). Written informed consents were obtained from the parents of the participating children.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Ahmed R. Alsuwaidi, Email: alsuwaidia@uaeu.ac.ae
Klaithem Al Dhaheri, Email: kmdhaheri@seha.ae.
Sania Al Hamad, Email: saniaalhamad@uaeu.ac.ae.
Junu George, Email: jibrahim@seha.ae.
Judy Ibrahim, Email: junugeorge@uaeu.ac.ae.
Ghassan Ghatasheh, Email: gghatasheh@seha.ae.
Mohammed Issa, Email: missah@seha.ae.
Suleiman Al-Hammadi, Email: suleiman.alhammadi@uaeu.ac.ae.
Hassib Narchi, Email: hassib.narchi@uaeu.ac.ae.
References
- 1.GBD 2016 Diarrhoeal Disease Collaborators Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1211–1228. doi: 10.1016/S1473-3099(18)30362-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Made S. GUIDE TO INFECTION CONTROL IN The HOSPITAL - diarrhea. In: ISID GUIDE TO INFECTION CONTROL IN THE HEALTHCARE SETTING https://isid.org/guide/hospital/diarrhea/. Accessed 28 Nov 2020.
- 3.Howidi M, Al Kaabi N, El Khoury AC, Brandtmüller A, Nagy L, Richer E, et al. Burden of acute gastroenteritis among children younger than 5 years of age--a survey among parents in the United Arab Emirates. BMC Pediatr. 2012;12:74. doi: 10.1186/1471-2431-12-74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Howidi M, Balhaj G, Yaseen H, Gopala K, Van Doorn LJ, DeAntonio R. Burden and genotyping of rotavirus disease in the United Arab Emirates: a multicenter hospital-based surveillance. Hum Vaccin Immunother. 2014;10:2284–2289. doi: 10.4161/hv.29386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Amjad M. An overview of the molecular methods in the diagnosis of gastrointestinal infectious diseases. Int J Microbiol. 2020;2020:8135724. doi: 10.1155/2020/8135724. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zhang H, Morrison S, Tang Y-W. Multiplex polymerase chain reaction tests for detection of pathogens associated with gastroenteritis. Clin Lab Med. 2015;35:461–486. doi: 10.1016/j.cll.2015.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gray J, Coupland LJ. The increasing application of multiplex nucleic acid detection tests to the diagnosis of syndromic infections. Epidemiol Infect. 2014;142:1–11. doi: 10.1017/S0950268813002367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tilmanne A, Martiny D, Quach C, Wautier M, Vandenberg O, Lepage P, et al. Enteropathogens in paediatric gastroenteritis: comparison of routine diagnostic and molecular methods. Clin Microbiol Infect. 2019;25:1519–1524. doi: 10.1016/j.cmi.2019.07.021. [DOI] [PubMed] [Google Scholar]
- 9.Statistics Centre - Abu Dhabi. Statistical Yearbook of Abu Dhabi 2020. https://www.scad.gov.ae/Release%20Documents/Statistical%20Yearbook%20of%20Abu%20Dhabi_2020_Annual_Yearly_en.pdf.
- 10.WHO Regional Office for the Eastern Mediterranean. Demographic, social and health indicators for countries of the Eastern Mediterranean 2011. 2011.
- 11.Zimmermann S, Horner S, Altwegg M, Dalpke AH. Workflow optimization for syndromic diarrhea diagnosis using the molecular Seegene Allplex™ GI-Bacteria(I) assay. Eur J Clin Microbiol Infect Dis. 2020. [DOI] [PMC free article] [PubMed]
- 12.Yoo J, Park J, Lee HK, Yu JK, Lee GD, Park KG, et al. Comparative evaluation of Seegene Allplex gastrointestinal, Luminex xTAG gastrointestinal pathogen panel, and BD MAX enteric assays for detection of gastrointestinal pathogens in clinical stool specimens. Arch Pathol Lab Med. 2019;143:999–1005. doi: 10.5858/arpa.2018-0002-OA. [DOI] [PubMed] [Google Scholar]
- 13.Operario DJ, Platts-Mills JA, Nadan S, Page N, Seheri M, Mphahlele J, et al. Etiology of severe acute watery diarrhea in children in the global rotavirus surveillance network using quantitative polymerase chain reaction. J Infect Dis. 2017;216:220–227. doi: 10.1093/infdis/jix294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Payne DC, Vinjé J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, et al. Norovirus and medically attended gastroenteritis in U.s. children. N Engl J Med. 2013;368:1121–1130. doi: 10.1056/NEJMsa1206589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.The ROTA Council. Global Introduction Status https://preventrotavirus.org/vaccine-introduction/global-introduction-status/. Accessed 28 Nov 2020.
- 16.Abou-Nader AJ, Sauer MA, Steele AD, Tate JE, Atherly D, Parashar UD, et al. Global rotavirus vaccine introductions and coverage: 2006–2016. Hum Vaccin Immunother. 2018;14:2281–2296. doi: 10.1080/21645515.2018.1470725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary Coverage time series for United Arab Emirates (ARE). https://apps.who.int/immunization_monitoring/globalsummary/coverages?c=ARE.
- 18.Department of Health - Abu Dhabi. Communicable Diseases Bulletin, Second Quarter– 2019 (Apr-Jun). 2019. file:///Users/aalsuwaidi/Downloads/Q22019%20CD%20Bulletin%20%20Vol201020Issue%2022022%20Dec%202019%20(5).pdf.
- 19.Kreidieh K, Charide R, Dbaibo G, Melhem NM. The epidemiology of Norovirus in the Middle East and North Africa (MENA) region: a systematic review. Virol J. 2017;14:220. doi: 10.1186/s12985-017-0877-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Cates JE, Vinjé J, Parashar U, Hall AJ. Recent advances in human norovirus research and implications for candidate vaccines. Expert Rev Vaccines. 2020;19:539–548. doi: 10.1080/14760584.2020.1777860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.La Rosa G, Della Libera S, Petricca S, Iaconelli M, Donia D, Saccucci P, et al. Genetic diversity of human adenovirus in children with acute gastroenteritis, Albania, 2013-2015. Biomed Res Int. 2015;2015:142912. doi: 10.1155/2015/627201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Moyo SJ, Hanevik K, Blomberg B, Kommedal O, Nordbø SA, Maselle S, et al. Prevalence and molecular characterisation of human adenovirus in diarrhoeic children in Tanzania; a case control study. BMC Infect Dis. 2014;14:666. doi: 10.1186/s12879-014-0666-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Qiu F-Z, Shen X-X, Li G-X, Zhao L, Chen C, Duan S-X, et al. Adenovirus associated with acute diarrhea: a case-control study. BMC Infect Dis. 2018;18:450. doi: 10.1186/s12879-018-3340-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sciandra I, Piccioni L, Coltella L, Ranno S, Giannelli G, Falasca F, et al. Comparative analysis of 2 commercial molecular tests for the detection of gastroenteric viruses on stool samples. Diagn Microbiol Infect Dis. 2020;96:114893. doi: 10.1016/j.diagmicrobio.2019.114893. [DOI] [PubMed] [Google Scholar]
- 25.Feghoul L, Chevret S, Cuinet A, Dalle J-H, Ouachée M, Yacouben K, et al. Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment. Clin Microbiol Infect. 2015;21:701–709. doi: 10.1016/j.cmi.2015.03.011. [DOI] [PubMed] [Google Scholar]
- 26.Trabulsi LR, Keller R, Tardelli Gomes TA. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis. 2002;8:508–513. doi: 10.3201/eid0805.010385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hu J, Torres AG. Enteropathogenic Escherichia coli: foe or innocent bystander? Clin Microbiol Infect. 2015;21:729–734. doi: 10.1016/j.cmi.2015.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Anderson NW, Tarr PI. Multiplex nucleic acid amplification testing to diagnose gut infections: challenges, opportunities, and result interpretation. Gastroenterol Clin N Am. 2018;47:793–812. doi: 10.1016/j.gtc.2018.07.006. [DOI] [PubMed] [Google Scholar]
- 29.Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017;65:e45–e80. doi: 10.1093/cid/cix669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bouzid M, Hunter PR, Chalmers RM, Tyler KM. Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev. 2013;26:115–134. doi: 10.1128/CMR.00076-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.ElBakri A, Mogane L, Ezzedine S, Potgieter N, Bessong P, AbuOdeh R, et al. Prevalence of CRYPTOSPORIDIUM SPP. among asymptomatic healthy expatriate workers in Sharjah, United Arab Emirates. Afr J Infect Dis. 2018;12:7–13. doi: 10.21010/ajid.v12i2.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhang S-X, Zhou Y-M, Xu W, Tian L-G, Chen J-X, Chen S-H, et al. Impact of co-infections with enteric pathogens on children suffering from acute diarrhea in Southwest China. Infect Dis Poverty. 2016;5:64. doi: 10.1186/s40249-016-0157-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Bhavnani D, Goldstick JE, Cevallos W, Trueba G, Eisenberg JNS. Synergistic effects between rotavirus and coinfecting pathogens on diarrheal disease: evidence from a community-based study in northwestern Ecuador. Am J Epidemiol. 2012;176:387–395. doi: 10.1093/aje/kws220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Eibach D, Krumkamp R, Hahn A, Sarpong N, Adu-Sarkodie Y, Leva A, et al. Application of a multiplex PCR assay for the detection of gastrointestinal pathogens in a rural African setting. BMC Infect Dis. 2016;16:150. doi: 10.1186/s12879-016-1481-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.